Point72 Asset Management, L.P. - 31 Dec 2025 SCHEDULE 13G/A Report for Avalo Therapeutics, Inc. Common Stock, par value $0.001 per share (AVTX)
- Filing Manager
- Point72 Asset Management, L.P.
- Reporting Manager
- Point72 Asset Management, L.P.
- Symbol
- AVTX
- Shares outstanding
- 17,928,629 shares
- Disclosed Ownership
- 627,502 shares
- Ownership
- 3.5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 17 Feb 2026, 16:33:07 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 14 Nov 2025
- SEC
- View on sec.gov
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 3.5% | 627,502 | 0 | 627,502 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Point72 Capital Advisors, Inc. | 3.5% | 627,502 | 0 | 627,502 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Steven A. Cohen | 3.5% | 627,502 | 0 | 627,502 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person |